The FDA approval of two CAR-T cell therapies has increased the popularity of chimeric antigen receptor (CAR)-engineered T cell therapy in academic and clinical settings. Creative Biolabs has developed a comprehensive platform for CAR-T cell-based drug discovery, providing GMP-level services for plasmid preparation, virus packaging, and T cell production to support the discovery of new therapies. Learn more about CAR-T cell therapy manufacturing: https://www.creative-biolabs.com/car-t/gmp-production-for-car-t-products.htm
"Great ideas, research and innovation can come from anyone – so often the best ideas do not have a voice. IdeaSpies provides a platform for people to share ideas that create a better world"
Jonathan Chrimes
IdeaSpies